Global OTC Pet Medication Market

OTC Pet Medication Comprehensive Study by Application (Fleas & Ticks, Pain Relief & Arthritis, Dewormers, Others), Form (Chewables & Tablets, Capsules & Ointment, Sprays, Others), Distribution Channel (Pet Specialty Stores, Veterinary Clinics, Drug & Pharmacy Stores, Online Retail, Others), End-Use (Dogs, Cats, Birds, Fish and Reptiles, Others) Players and Region - Global Market Outlook to 2026

OTC Pet Medication Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
The study covers a detailed analysis segmented by key business segments i.e. , by application (Fleas & Ticks, Pain Relief & Arthritis, Dewormers and Others) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global OTC Pet Medication market throughout the predicted period.

What is OTC Pet Medication?
OTC (over-the-counter) medications are those that can be purchased without a doctor's prescription. Flea and tick dermatitis treatment is available over-the-counter for pets. Ache, pains, and itching are relieved by this over-the-counter treatment. The FDA/EPA has approved these drugs, which enhances demand for them. Dietary supplements, foods, beverages, and other drugs are examples of over-the-counter medications. Since pets require vitamins and minerals, over-the-counter medications can support them and improve their health. They're available via online outlets, where they're offered at low rates with free shipping. Customers can save money on checkups by using over-the-counter pet medicine. Since pets require vitamins and minerals, over-the-counter medications can support them and improve their health. They're available via online outlets, where they're offered at low rates with free shipping. Customers can save money on checkups by using over-the-counter pet medicine. To ensure the wellbeing of pets, consumers must have a thorough understanding of the advantages and side effects of OTC medications. Changes in lifestyle, increased disposable income, and more people having pets as companions have all contributed to an increase in pet ownership around the world. As a result of these factors, subsequent or related industries, such as OTC pet medication, are growing. The demand for OTC pet medication has been fueled by rising pet ownership and increased awareness of pet diseases and wellbeing.

The competition is expected to become even more intense in the years to come due to entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this OTC Pet Medication market analysis report suggests strategies Players can follow and recommends key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, including:
  • Boehringer Ingelheim Animal Health (France)
  • WELLMARK INTERNATIONAL (France)
  • Merck Animal Health (Merck & Co., Inc.) (United States)
  • Pfizer Inc. (United States)
  • Bayer AG (Germany)
  • Zoetis Inc (United States)
  • CevaSanteAnimale S.A. (France)
  • PetCareRx (United States)
  • Eli Lilly and Company (United States)
  • Elanco (United States)


Under the Federal Food, Drug, and Cosmetic Act (the “Act”), The Act defines a new animal drug (in part) as any drug intended for use for animals other than man, the composition of which is not generally recognized, among experts qualified by scientific training and experience, as safe and effective for use under the conditions prescribed, recommended, or suggested in its labeling., According to FDA –, Before a new animal drug may receive FDA approval, the sponsor must establish that the new animal drug is safe and effective. and Safe includes safety to the animal, safety of food products derived from the animal, and safety to persons administering the drug or otherwise associated with the animal. Effective means that the product will consistently and uniformly do what the labeling claims it will do.
The market is highly competitive with several global and local players present in the market, the major players are trying to gain competitive advantage using various mergers and tie-ups and also increasing awareness among people through advertisements.

Market Trend
Growing Adoption of Pets
Restraints
  • Adverse Reaction of Some Drugs on Pets

Opportunities
Increased Investment in R&D Of Dog Health and Growing Number of Vets in Developing Countries

Key highlights of the Global OTC Pet Medication market Study:
• CAGR of the market during the forecast period 2020-2026
• In-depth information on growth factors that will accelerate the OTC Pet Medication market in next few years.
• Detailed Insights on futuristic trends and changing consumer behaviour
• Forecast of the Global OTC Pet Medication market size and its contribution to the parent market by type, application and by country.
• A broad view of customer demand
• Uncover market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of OTC Pet Medication Players

Transformation and Important Trigegrs:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
• A tipping point in globalization
• A major slowdown in Western economies
• Significant shifts in technology and cost structure
• The challenges of regulatory compliance
• New forms of competition developing

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global OTC Pet Medication market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in OTC Pet Medication market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Manufacturers of OTC Pet Medication, Suppliers of OTC Pet Medication, Wholesalers, Distributors and Retailers of OTC Pet Medication, Pharmaceutical Industry, Regulatory Bodies and Others.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Application
  • Fleas & Ticks
  • Pain Relief & Arthritis
  • Dewormers
  • Others
By Form
  • Chewables & Tablets
  • Capsules & Ointment
  • Sprays
  • Others

By Distribution Channel
  • Pet Specialty Stores
  • Veterinary Clinics
  • Drug & Pharmacy Stores
  • Online Retail
  • Others

By End-Use
  • Dogs
  • Cats
  • Birds
  • Fish and Reptiles
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand For Animal Welfare
      • 3.2.2. Increased Awareness about Animal Health
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness about Dog Health in Some Countries
      • 3.3.2. Manufactures have to comply with the Drug Regulations
    • 3.4. Market Trends
      • 3.4.1. Growing Adoption of Pets
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global OTC Pet Medication, by Application, Form, Distribution Channel, End-Use and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global OTC Pet Medication (Value)
      • 5.2.1. Global OTC Pet Medication by: Application (Value)
        • 5.2.1.1. Fleas & Ticks
        • 5.2.1.2. Pain Relief & Arthritis
        • 5.2.1.3. Dewormers
        • 5.2.1.4. Others
      • 5.2.2. Global OTC Pet Medication by: Form (Value)
        • 5.2.2.1. Chewables & Tablets
        • 5.2.2.2. Capsules & Ointment
        • 5.2.2.3. Sprays
        • 5.2.2.4. Others
      • 5.2.3. Global OTC Pet Medication by: Distribution Channel (Value)
        • 5.2.3.1. Pet Specialty Stores
        • 5.2.3.2. Veterinary Clinics
        • 5.2.3.3. Drug & Pharmacy Stores
        • 5.2.3.4. Online Retail
        • 5.2.3.5. Others
      • 5.2.4. Global OTC Pet Medication by: End-Use (Value)
        • 5.2.4.1. Dogs
        • 5.2.4.2. Cats
        • 5.2.4.3. Birds
        • 5.2.4.4. Fish and Reptiles
        • 5.2.4.5. Others
      • 5.2.5. Global OTC Pet Medication Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. OTC Pet Medication: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boehringer Ingelheim Animal Health (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. WELLMARK INTERNATIONAL (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck Animal Health (Merck & Co., Inc.) (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bayer AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Zoetis Inc (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. CevaSanteAnimale S.A. (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. PetCareRx (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eli Lilly and Company (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Elanco (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global OTC Pet Medication Sale, by Application, Form, Distribution Channel, End-Use and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global OTC Pet Medication (Value)
      • 7.2.1. Global OTC Pet Medication by: Application (Value)
        • 7.2.1.1. Fleas & Ticks
        • 7.2.1.2. Pain Relief & Arthritis
        • 7.2.1.3. Dewormers
        • 7.2.1.4. Others
      • 7.2.2. Global OTC Pet Medication by: Form (Value)
        • 7.2.2.1. Chewables & Tablets
        • 7.2.2.2. Capsules & Ointment
        • 7.2.2.3. Sprays
        • 7.2.2.4. Others
      • 7.2.3. Global OTC Pet Medication by: Distribution Channel (Value)
        • 7.2.3.1. Pet Specialty Stores
        • 7.2.3.2. Veterinary Clinics
        • 7.2.3.3. Drug & Pharmacy Stores
        • 7.2.3.4. Online Retail
        • 7.2.3.5. Others
      • 7.2.4. Global OTC Pet Medication by: End-Use (Value)
        • 7.2.4.1. Dogs
        • 7.2.4.2. Cats
        • 7.2.4.3. Birds
        • 7.2.4.4. Fish and Reptiles
        • 7.2.4.5. Others
      • 7.2.5. Global OTC Pet Medication Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. OTC Pet Medication: by Application(USD Million)
  • Table 2. OTC Pet Medication Fleas & Ticks , by Region USD Million (2015-2020)
  • Table 3. OTC Pet Medication Pain Relief & Arthritis , by Region USD Million (2015-2020)
  • Table 4. OTC Pet Medication Dewormers , by Region USD Million (2015-2020)
  • Table 5. OTC Pet Medication Others , by Region USD Million (2015-2020)
  • Table 6. OTC Pet Medication: by Form(USD Million)
  • Table 7. OTC Pet Medication Chewables & Tablets , by Region USD Million (2015-2020)
  • Table 8. OTC Pet Medication Capsules & Ointment , by Region USD Million (2015-2020)
  • Table 9. OTC Pet Medication Sprays , by Region USD Million (2015-2020)
  • Table 10. OTC Pet Medication Others , by Region USD Million (2015-2020)
  • Table 11. OTC Pet Medication: by Distribution Channel(USD Million)
  • Table 12. OTC Pet Medication Pet Specialty Stores , by Region USD Million (2015-2020)
  • Table 13. OTC Pet Medication Veterinary Clinics , by Region USD Million (2015-2020)
  • Table 14. OTC Pet Medication Drug & Pharmacy Stores , by Region USD Million (2015-2020)
  • Table 15. OTC Pet Medication Online Retail , by Region USD Million (2015-2020)
  • Table 16. OTC Pet Medication Others , by Region USD Million (2015-2020)
  • Table 17. OTC Pet Medication: by End-Use(USD Million)
  • Table 18. OTC Pet Medication Dogs , by Region USD Million (2015-2020)
  • Table 19. OTC Pet Medication Cats , by Region USD Million (2015-2020)
  • Table 20. OTC Pet Medication Birds , by Region USD Million (2015-2020)
  • Table 21. OTC Pet Medication Fish and Reptiles , by Region USD Million (2015-2020)
  • Table 22. OTC Pet Medication Others , by Region USD Million (2015-2020)
  • Table 23. South America OTC Pet Medication, by Country USD Million (2015-2020)
  • Table 24. South America OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 25. South America OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 26. South America OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 27. South America OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 28. Brazil OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 29. Brazil OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 30. Brazil OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 31. Brazil OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 32. Argentina OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 33. Argentina OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 34. Argentina OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 35. Argentina OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 36. Rest of South America OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 37. Rest of South America OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 38. Rest of South America OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 39. Rest of South America OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 40. Asia Pacific OTC Pet Medication, by Country USD Million (2015-2020)
  • Table 41. Asia Pacific OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 42. Asia Pacific OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 43. Asia Pacific OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 44. Asia Pacific OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 45. China OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 46. China OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 47. China OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 48. China OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 49. Japan OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 50. Japan OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 51. Japan OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 52. Japan OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 53. India OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 54. India OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 55. India OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 56. India OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 57. South Korea OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 58. South Korea OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 59. South Korea OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 60. South Korea OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 61. Taiwan OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 62. Taiwan OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 63. Taiwan OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 64. Taiwan OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 65. Australia OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 66. Australia OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 67. Australia OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 68. Australia OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 73. Europe OTC Pet Medication, by Country USD Million (2015-2020)
  • Table 74. Europe OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 75. Europe OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 76. Europe OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 77. Europe OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 78. Germany OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 79. Germany OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 80. Germany OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 81. Germany OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 82. France OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 83. France OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 84. France OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 85. France OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 86. Italy OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 87. Italy OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 88. Italy OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 89. Italy OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 90. United Kingdom OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 91. United Kingdom OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 92. United Kingdom OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 93. United Kingdom OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 94. Netherlands OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 95. Netherlands OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 96. Netherlands OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 97. Netherlands OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 98. Rest of Europe OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 99. Rest of Europe OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 100. Rest of Europe OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 101. Rest of Europe OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 102. MEA OTC Pet Medication, by Country USD Million (2015-2020)
  • Table 103. MEA OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 104. MEA OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 105. MEA OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 106. MEA OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 107. Middle East OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 108. Middle East OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 109. Middle East OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 110. Middle East OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 111. Africa OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 112. Africa OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 113. Africa OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 114. Africa OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 115. North America OTC Pet Medication, by Country USD Million (2015-2020)
  • Table 116. North America OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 117. North America OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 118. North America OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 119. North America OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 120. United States OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 121. United States OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 122. United States OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 123. United States OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 124. Canada OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 125. Canada OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 126. Canada OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 127. Canada OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 128. Mexico OTC Pet Medication, by Application USD Million (2015-2020)
  • Table 129. Mexico OTC Pet Medication, by Form USD Million (2015-2020)
  • Table 130. Mexico OTC Pet Medication, by Distribution Channel USD Million (2015-2020)
  • Table 131. Mexico OTC Pet Medication, by End-Use USD Million (2015-2020)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. OTC Pet Medication: by Application(USD Million)
  • Table 143. OTC Pet Medication Fleas & Ticks , by Region USD Million (2021-2026)
  • Table 144. OTC Pet Medication Pain Relief & Arthritis , by Region USD Million (2021-2026)
  • Table 145. OTC Pet Medication Dewormers , by Region USD Million (2021-2026)
  • Table 146. OTC Pet Medication Others , by Region USD Million (2021-2026)
  • Table 147. OTC Pet Medication: by Form(USD Million)
  • Table 148. OTC Pet Medication Chewables & Tablets , by Region USD Million (2021-2026)
  • Table 149. OTC Pet Medication Capsules & Ointment , by Region USD Million (2021-2026)
  • Table 150. OTC Pet Medication Sprays , by Region USD Million (2021-2026)
  • Table 151. OTC Pet Medication Others , by Region USD Million (2021-2026)
  • Table 152. OTC Pet Medication: by Distribution Channel(USD Million)
  • Table 153. OTC Pet Medication Pet Specialty Stores , by Region USD Million (2021-2026)
  • Table 154. OTC Pet Medication Veterinary Clinics , by Region USD Million (2021-2026)
  • Table 155. OTC Pet Medication Drug & Pharmacy Stores , by Region USD Million (2021-2026)
  • Table 156. OTC Pet Medication Online Retail , by Region USD Million (2021-2026)
  • Table 157. OTC Pet Medication Others , by Region USD Million (2021-2026)
  • Table 158. OTC Pet Medication: by End-Use(USD Million)
  • Table 159. OTC Pet Medication Dogs , by Region USD Million (2021-2026)
  • Table 160. OTC Pet Medication Cats , by Region USD Million (2021-2026)
  • Table 161. OTC Pet Medication Birds , by Region USD Million (2021-2026)
  • Table 162. OTC Pet Medication Fish and Reptiles , by Region USD Million (2021-2026)
  • Table 163. OTC Pet Medication Others , by Region USD Million (2021-2026)
  • Table 164. South America OTC Pet Medication, by Country USD Million (2021-2026)
  • Table 165. South America OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 166. South America OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 167. South America OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 168. South America OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 169. Brazil OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 170. Brazil OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 171. Brazil OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 172. Brazil OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 173. Argentina OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 174. Argentina OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 175. Argentina OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 176. Argentina OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 177. Rest of South America OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 178. Rest of South America OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 179. Rest of South America OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 180. Rest of South America OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 181. Asia Pacific OTC Pet Medication, by Country USD Million (2021-2026)
  • Table 182. Asia Pacific OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 183. Asia Pacific OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 184. Asia Pacific OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 185. Asia Pacific OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 186. China OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 187. China OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 188. China OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 189. China OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 190. Japan OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 191. Japan OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 192. Japan OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 193. Japan OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 194. India OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 195. India OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 196. India OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 197. India OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 198. South Korea OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 199. South Korea OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 200. South Korea OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 201. South Korea OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 202. Taiwan OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 203. Taiwan OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 204. Taiwan OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 205. Taiwan OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 206. Australia OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 207. Australia OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 208. Australia OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 209. Australia OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 210. Rest of Asia-Pacific OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 211. Rest of Asia-Pacific OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 212. Rest of Asia-Pacific OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 213. Rest of Asia-Pacific OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 214. Europe OTC Pet Medication, by Country USD Million (2021-2026)
  • Table 215. Europe OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 216. Europe OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 217. Europe OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 218. Europe OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 219. Germany OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 220. Germany OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 221. Germany OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 222. Germany OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 223. France OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 224. France OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 225. France OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 226. France OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 227. Italy OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 228. Italy OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 229. Italy OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 230. Italy OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 231. United Kingdom OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 232. United Kingdom OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 233. United Kingdom OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 234. United Kingdom OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 235. Netherlands OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 236. Netherlands OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 237. Netherlands OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 238. Netherlands OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 239. Rest of Europe OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 240. Rest of Europe OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 241. Rest of Europe OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 242. Rest of Europe OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 243. MEA OTC Pet Medication, by Country USD Million (2021-2026)
  • Table 244. MEA OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 245. MEA OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 246. MEA OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 247. MEA OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 248. Middle East OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 249. Middle East OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 250. Middle East OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 251. Middle East OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 252. Africa OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 253. Africa OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 254. Africa OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 255. Africa OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 256. North America OTC Pet Medication, by Country USD Million (2021-2026)
  • Table 257. North America OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 258. North America OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 259. North America OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 260. North America OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 261. United States OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 262. United States OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 263. United States OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 264. United States OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 265. Canada OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 266. Canada OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 267. Canada OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 268. Canada OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 269. Mexico OTC Pet Medication, by Application USD Million (2021-2026)
  • Table 270. Mexico OTC Pet Medication, by Form USD Million (2021-2026)
  • Table 271. Mexico OTC Pet Medication, by Distribution Channel USD Million (2021-2026)
  • Table 272. Mexico OTC Pet Medication, by End-Use USD Million (2021-2026)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global OTC Pet Medication: by Application USD Million (2015-2020)
  • Figure 5. Global OTC Pet Medication: by Form USD Million (2015-2020)
  • Figure 6. Global OTC Pet Medication: by Distribution Channel USD Million (2015-2020)
  • Figure 7. Global OTC Pet Medication: by End-Use USD Million (2015-2020)
  • Figure 8. South America OTC Pet Medication Share (%), by Country
  • Figure 9. Asia Pacific OTC Pet Medication Share (%), by Country
  • Figure 10. Europe OTC Pet Medication Share (%), by Country
  • Figure 11. MEA OTC Pet Medication Share (%), by Country
  • Figure 12. North America OTC Pet Medication Share (%), by Country
  • Figure 13. Global OTC Pet Medication share by Players 2020 (%)
  • Figure 14. Global OTC Pet Medication share by Players (Top 3) 2020(%)
  • Figure 15. Global OTC Pet Medication share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Boehringer Ingelheim Animal Health (France) Revenue, Net Income and Gross profit
  • Figure 18. Boehringer Ingelheim Animal Health (France) Revenue: by Geography 2020
  • Figure 19. WELLMARK INTERNATIONAL (France) Revenue, Net Income and Gross profit
  • Figure 20. WELLMARK INTERNATIONAL (France) Revenue: by Geography 2020
  • Figure 21. Merck Animal Health (Merck & Co., Inc.) (United States) Revenue, Net Income and Gross profit
  • Figure 22. Merck Animal Health (Merck & Co., Inc.) (United States) Revenue: by Geography 2020
  • Figure 23. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 25. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 27. Zoetis Inc (United States) Revenue, Net Income and Gross profit
  • Figure 28. Zoetis Inc (United States) Revenue: by Geography 2020
  • Figure 29. CevaSanteAnimale S.A. (France) Revenue, Net Income and Gross profit
  • Figure 30. CevaSanteAnimale S.A. (France) Revenue: by Geography 2020
  • Figure 31. PetCareRx (United States) Revenue, Net Income and Gross profit
  • Figure 32. PetCareRx (United States) Revenue: by Geography 2020
  • Figure 33. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 34. Eli Lilly and Company (United States) Revenue: by Geography 2020
  • Figure 35. Elanco (United States) Revenue, Net Income and Gross profit
  • Figure 36. Elanco (United States) Revenue: by Geography 2020
  • Figure 37. Global OTC Pet Medication: by Application USD Million (2021-2026)
  • Figure 38. Global OTC Pet Medication: by Form USD Million (2021-2026)
  • Figure 39. Global OTC Pet Medication: by Distribution Channel USD Million (2021-2026)
  • Figure 40. Global OTC Pet Medication: by End-Use USD Million (2021-2026)
  • Figure 41. South America OTC Pet Medication Share (%), by Country
  • Figure 42. Asia Pacific OTC Pet Medication Share (%), by Country
  • Figure 43. Europe OTC Pet Medication Share (%), by Country
  • Figure 44. MEA OTC Pet Medication Share (%), by Country
  • Figure 45. North America OTC Pet Medication Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Boehringer Ingelheim Animal Health (France)
  • WELLMARK INTERNATIONAL (France)
  • Merck Animal Health (Merck & Co., Inc.) (United States)
  • Pfizer Inc. (United States)
  • Bayer AG (Germany)
  • Zoetis Inc (United States)
  • CevaSanteAnimale S.A. (France)
  • PetCareRx (United States)
  • Eli Lilly and Company (United States)
  • Elanco (United States)
Additional players considered in the study are as follows:
Alivira Animal Health Ltd. (India) , HEARTGARD Plus (United States) , Zovix Pharmaceuticals (India) , AdvaCare Pharma (India)
Select User Access Type

Key Highlights of Report


Apr 2021 231 Pages 96 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global OTC Pet Medication Market Quantitative research analysis
Global OTC Pet Medication Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

OTC Pet Medication Market is heading robustly to achieve new growth cycle.
The Concentration Rate of Global OTC Pet Medication market is dominated by United States Players to generate healthy valuation by 2026.
Companies that are profiled in Global OTC Pet Medication Market are Boehringer Ingelheim Animal Health (France), WELLMARK INTERNATIONAL (France), Merck Animal Health (Merck & Co., Inc.) (United States), Pfizer Inc. (United States), Bayer AG (Germany), Zoetis Inc (United States), CevaSanteAnimale S.A. (France), PetCareRx (United States), Eli Lilly and Company (United States) and Elanco (United States) etc.

Know More About Global OTC Pet Medication Market Report?

Have a Query? Click Here

Other Related Reports

Carglumic Acid Comprehensive Study by Form (Orally Disintegrating Tablets, Dispersible Tablets), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce Channel) Players and Region -...
$ 3500
Risedronate Sodiums Comprehensive Study by Type (Generic, Branded), Application (Hospital Use, Clinic Use), Risedronate Strength (5 mg, 30 mg, 35 mg), Dosage Form (Capsule, Tablet, Injection) Player...
$ 3500
Palbociclib Comprehensive Study by Type (Tablets, Capsules), Distribution Channel (Online Pharmacies, Retail Pharmacies), End-Users (Hospitals, Diagnostic Centres, Research Institutes), Strength (5mg...
$ 3500
Antibiotics Active Pharmaceutical Ingredient Comprehensive Study by Type (Penicillin Antibiotics, Cephalosporins, Carbapenem Antibiotics), Application (Pharmaceutical Companies, Contract Manufacturin...
$ 3450
Levothyroxine Sodium Tablet Comprehensive Study by Application (Hospital, Specialty Clinic), Treatment (Goiters, Thyroid cancer), Packaging (Bottle, Blister), Dosage (25mcg – 50mcg, 50mcg – 75mcg, 75...
$ 3350
Trulicity Comprehensive Study by Distribution Channel (Specialty Pharma Retail Stores, Hospitals Pharma), Dosage (Less than 1mg, 1mg - 2mg, 2mg - 3mg, 3mg - 4mg, More than 4mg) Players and Region - G...
$ 3500